Results 61 to 70 of about 110,265 (199)

Stent implantation in a left ventricular assist device

REC: Interventional Cardiology (English Ed.), 2020
Sixty-eight-year-old male patient carrier of one HeartWare left ventricular assist device as destination therapy due to ischemic dilated cardiomyopathy.
Raquel Álvarez Ramos, Luis María Andrés Lalaguna, José Luis Díez Gil   +2 more
doaj   +1 more source

The impact of peripheral arterial disease on patients with mechanical circulatory support. [PDF]

, 2020
Background: Left ventricular assist devices (LVAD) are indicated as bridging or destination therapy for patients with advanced (Stage D) heart failure and reduced ejection fraction (HFrEF). Due to the clustering of the mutual risk factors, HFrEF patients
Ajmal, Rasikh, Al-Khadra, Yasser, Alraies, M Chadi, Asfour, Abedelrahim, Darmoch, Fahed, Gardi, Delair, Glazier, James, Mir, Tanveer, Moussa-Pacha, Homam, Sattar, Yasar, Ullah, Waqas   +10 more
core   +1 more source

A taxonomy of epithelial human cancer and their metastases [PDF]

, 2009
Background: Microarray technology has allowed to molecularly characterize many different cancer sites. This technology has the potential to individualize therapy and to discover new drug targets.
Olivier Gevaert, Anneleen Daemen, Bart De Moor, Louis Libbrecht, CH Chung, TR Golub, B Weigelt, T Sorlie, DN Hayes, CM Perou, A Bhattacharjee, A Alizadeh, T Sorlie, S Ramaswamy, TJ Giordano, D Rhodes, S Ramaswamy, GV Glinsky, N Pavlidis, RW Tothill, RA Bender, G Bloom, XJ Ma, D Talantov, CL Wilson, M Dai, A Subramanian, G Dennis, DW Huang, PS Nelson, M Cuatrecasas, JH Eichhorn, SK Tickoo, G Ayala, J Brugarolas, P Staller, X Liu, BJ Yoder, M Lacroix, B Weigelt, C Sotiriou, EA Rakha, C Sotiriou, AV Ivshina, M Ignatiadis, JX Yu, Z Hu, EK Sloan, AK Witkiewicz, L Lukes, AK Witkiewicz, XJ Ma, K Pavlakis, S Troup, K Wennmalm, P Schedin, G Finak, KA Oien, HG Laberke, MB Amin, SJ Jung, RC Bast Jr, JD Seidman, H Kang, H Naora, SM Smorenburg, T Sukata, IJ Matouk, S Khambata-Ford, MA Pantaleo, DH Ki, A Ramasamy, M Snyder, J Belmont, K Chin, LD Miller, J Pittman   +76 more
core   +3 more sources

Mechanical Circulatory Support and the Role of LVADs in Heart Failure Therapy

Clinical Medicine Insights: Cardiology, 2015
Heart failure is epidemic in the United States with a prevalence of over 5 million. The diagnosis carries a mortality risk of 50% at 5 years rivaling many diagnoses of cancer.
Allison McLarty
doaj   +1 more source

Charles Keene College of Further Education (FEFC inspection report; 45/96) [PDF]

, 1996
Further Education Funding Council (FEFC) inspection report for the period 1995-96 (45/96). The FEFC has a legal duty to make sure further education in England is properly assessed.

core  

LVAD as destination therapy - the economic dilemma

IEEE Technology and Society Magazine, 2004
The artificial heart, after decades of development, remains a long way off as a practical remedy for people with failing hearts. But a related technology, the left ventricular assist device (LVAD), has passed major milestones in its development and is poised for widespread use.
Douglas, Pamela, Morgan, Courtney, Lee, Heather, Foster, Kenneth R.   +3 more
openaire   +3 more sources

МЕТАФОРИЧНА ОБ’ЄКТИВАЦІЯ ГРУПОВОЇ ТЕРАПІЇ У ПСИХОТЕРАПЕВТИЧНОМУ ДИСКУРСІ (НА МАТЕРІАЛІ РОМАНУ ІРВІНА ЯЛОМА THE SCHOPENHAUER CURE)

Folium
Стаття присвячена дослідженню психотерапевтичного дискурсу сучасного лікаря-психотерапевта і письменника Ірвіна Ялома у фокусі когнітивно-лінгвістичних студій. Метою розвідки є з’ясування діапазону концептуальних метафор з цільовими доменами THERAPEUTIC
Оксана Дойчик, Ірина Шкорута   +1 more
doaj   +1 more source

RoboChain: A Secure Data-Sharing Framework for Human-Robot Interaction

, 2018
Robots have potential to revolutionize the way we interact with the world around us. One of their largest potentials is in the domain of mobile health where they can be used to facilitate clinical interventions.
Ferrer, Eduardo Castelló, Hardjono, Thomas, Pentland, Alex, Rudovic, Ognjen   +3 more
core  

Left Ventricular Assist Device as Destination Therapy

The VAD Journal, 2014
Mechanical circulatory support is the most rapidly evolving strategy in heart failure management. The growing number of patients who need better results than medical therapy can offer, the limited pool of donors for cardiac transplantation, and several technological breakthroughs have all made the option of implanting a left ventricular assist device ...
Guglin, Maya, Miller, Leslie W.
openaire   +2 more sources

Predicting Bleeding and Thrombosis Complications in Patients with Continuous Flow Left Ventricular Assist Devices [PDF]

, 2020
Background: Left ventricular assist device (LVAD) therapy has been proven to relieve heart failure symptoms and improve survival, but is not devoid of bleeding and/or thrombotic complications.
Cook, Aaron, Kuan, William, McCann, Justin McCann, Parli, Sara, Schadler, Aric, Sieg, Adam, Zacholski, Kyle   +6 more
core   +1 more source